ArticleFrontiers in pharmacology2022

Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis.

Vivaswath S Ayyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.